Neoadjuvant Systemic Therapy for Resectable Intrahepatic Cholangiocarcinoma: From Retrospective Studies to Randomized Evidence
Simple Summary Intrahepatic cholangiocarcinoma is an aggressive bile duct cancer that arises within the liver and frequently recurs after surgery. Administering anticancer treatment before surgery may treat occult disease earlier and help identify patients most likely to benefit from major liver surgery; however, this...